Qube Research & Technologies LTD Trans Medics Group, Inc. Call Options Transaction History
Qube Research & Technologies LTD
- $62.3 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding TMDX
# of Institutions
381Shares Held
31.4MCall Options Held
410KPut Options Held
152K-
Vanguard Group Inc Valley Forge, PA3.6MShares$329 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$242 Million0.01% of portfolio
-
Driehaus Capital Management LLC Chicago, IL1.49MShares$136 Million2.41% of portfolio
-
Eventide Asset Management, LLC Boston, MA1.15MShares$105 Million3.04% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO1.14MShares$104 Million2.26% of portfolio
About TransMedics Group, Inc.
- Ticker TMDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 31,831,400
- Market Cap $2.91B
- Description
- TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...